LAS VEGAS--(BUSINESS WIRE)--Regenerex Pharma, Inc. (OTC: RGPX), announces the establishment of its comprehensive management team and the commencement of the Company manufacturing plans in Q4 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback